Phagos

The Sustainable Alternative to Antibiotics

Phagos was founded in 2021, is headquartered in Suresnes, France, lists 11–50 employees, and has $29.2M in recorded funding across 1 round.

Employees
11–50
Founded
2021
Business Model
B2B
Website
phagos.com
Total Funding
$29.2M
Last Round
$29.2M Series AOct 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 8 investors for this company. The full record is or through the API.

About

Phagos develops bacteriophage therapies as a sustainable alternative to antibiotics, combining microbiology with artificial intelligence to create personalized bacterial treatments. The company uses patented technology to produce large-scale, customized phage-based veterinary medicines and plans to extend the approach to human health. Its mission is to end bacterial disease by using phages, the natural predators of bacteria, to address antibiotic resistance. Phagos reports about 50 employees across microbiology and AI, 11 clinical trials of AI-powered phage treatments, and roughly one million animals treated in the field.

Summary

Phagos is an Artificial Intelligence company based in Suresnes, France, founded in 2021. It lists 11–50 employees. It has raised $29.2M in total across 1 round, most recently a $29.2M Series A round in Oct 2025. Investors include Capagro, Hoxton Ventures and CapHorn Invest.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AOct 2025
$29.2M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Phagos on Indexed.vc
<a href="https://indexed.vc/companies/phagos"><img src="https://indexed.vc/api/badge/company/phagos" alt="Phagos on Indexed.vc" width="260" height="76" /></a>